GlassScriptPhysician profile
Craig E Mcknight
NPI 1952445272
$4,922.32
in general payments reported to CMS, 2019-2025
19 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $3,300 · 2021: $326 · 2022: $236 · 2023: $431 · 2024: $115 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778 · Education: $97.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.82 |
| Education | $97.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $3,300.31 | 2020 | |
| Coloplast Corp | $363.91 | 2021-2022 | |
| Astellas Pharma US INC | $250.82 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $173.22 | 2022-2024 | |
| Saluda Medical Americas, INC. | $152.22 | 2025 | Evoke |
| Boston Scientific Corporation | $116.56 | 2025 | Wavewriter Alpha Prime 16 |
| Mml US, INC. | $110.05 | 2023 | Reactiv8 |
| Amgen INC. | $106.63 | 2021-2023 | Evenity, Prolia |
| Sumitomo Pharma America, INC. | $90.51 | 2024-2025 | Gemtesa |
| Abbott Laboratories | $85.06 | 2019 | |
| Novo Nordisk INC | $29.97 | 2019-2022 | |
| Daiichi Sankyo INC. | $22.28 | 2019 | |
| Abbvie INC. | $21.09 | 2023 | |
| Allergan, INC. | $20.06 | 2019 | |
| Urovant Sciences INC | $19.70 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.13 | 2023 | Trulance, Xifaxan |
| Merck Sharp & Dohme LLC | $14.03 | 2021 | |
| Therapeuticsmd, INC. | $13.91 | 2019 | |
| Exeltis, USA INC. | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Mcknight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.